Loading...

S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide

S100A4 (metastasin-1), a metastasis-associated protein and marker of the epithelial to mesenchymal transition, contributes to several hallmarks of cancer and has been implicated in the progression of several types of cancer. However, the impacts of S100A4 signaling in lung cancer progression and its...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Stewart, Rachel L., Carpenter, Brittany L., West, Dava S., Knifley, Teresa, Liu, Lili, Wang, Chi, Weiss, Heidi L., Gal, Tamas S., Durbin, Eric B., Arnold, Susanne M., O'Connor, Kathleen L., Chen, Min
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085181/
https://ncbi.nlm.nih.gov/pubmed/27127879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8969
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!